Patents by Inventor Xichen Lin

Xichen Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic GLP-1 agonists
    Patent number: 12595264
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: April 7, 2026
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20260055069
    Abstract: This disclosure relates to GLP-1 agonists of Formula I. including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 28, 2025
    Publication date: February 26, 2026
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 12552791
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: March 18, 2025
    Date of Patent: February 17, 2026
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Andrew Jennings, Hui Lei, Xichen Lin
  • Heterocyclic GLP-1 agonists
    Patent number: 12528781
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: December 8, 2023
    Date of Patent: January 20, 2026
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20250250269
    Abstract: The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.
    Type: Application
    Filed: April 13, 2023
    Publication date: August 7, 2025
    Inventors: Xichen LIN, Qinghua MENG, Weiqiang XING, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20250214999
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: March 18, 2025
    Publication date: July 3, 2025
    Inventors: Qinghua MENG, Andrew JENNINGS, Hui LEI, Xichen LIN
  • 5,8-DIHYDRO-1,7-NAPHTHYRIDINE DERIVATIVES AS GLP-1 AGONISTS FOR THE TREATMENT OF DIABETES
    Publication number: 20250206757
    Abstract: The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.
    Type: Application
    Filed: March 20, 2023
    Publication date: June 26, 2025
    Inventors: Hui LEI, Xichen LIN, Qinghua MENG, Haizhen ZHANG
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20250188103
    Abstract: This disclosure relates to GLP-1 agonists, pharmaceutical compositions, and methods of use thereof.
    Type: Application
    Filed: March 8, 2023
    Publication date: June 12, 2025
    Inventors: Xichen LIN, Qinghua MENG, Weiqiang XING, Zhongmiao XU
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20250115606
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: December 17, 2024
    Publication date: April 10, 2025
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • Heterocyclic GLP-1 agonists
    Patent number: 12221442
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: January 26, 2024
    Date of Patent: February 11, 2025
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20240376061
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: December 8, 2023
    Publication date: November 14, 2024
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20240366639
    Abstract: GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: August 12, 2022
    Publication date: November 7, 2024
    Inventors: Qinghua MENG, Xichen LIN, Haizhen ZHANG, Weiqiang XING, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20240246962
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: January 26, 2024
    Publication date: July 25, 2024
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20240083886
    Abstract: Relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 13, 2021
    Publication date: March 14, 2024
    Inventors: Qinghua MENG, Weiqiang XING, Xichen LIN, Andrew JENNINGS
  • Heterocyclic GLP-1 agonists
    Patent number: 11926626
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: September 21, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Weiqiang Xing, Haizhen Zhang, Xichen Lin, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11926643
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: March 12, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Xichen Lin, Haizhen Zhang, Weiqiang Xing, Hui Lei, Andrew Jennings
  • Heterocyclic GLP-1 agonists
    Patent number: 11897851
    Abstract: This disclosure relates to GLP-1 agonists of Formula I: including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Grant
    Filed: February 6, 2023
    Date of Patent: February 13, 2024
    Assignee: Gasherbrum Bio, Inc.
    Inventors: Qinghua Meng, Hui Lei, Haizhen Zhang, Xichen Lin, Andrew Jennings
  • COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH LPA RECEPTOR ACTIVITY
    Publication number: 20240018102
    Abstract: This disclosure relates to LPA antagonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 21, 2021
    Publication date: January 18, 2024
    Applicant: Lhotse Bio, Inc
    Inventors: Haizhen Zhang, Michael Hanson, Andrew Jennings, Hui Lei, Xichen Lin, Qiong Zhang, Alexandre Cote, Anatoly M. Ruvinsky
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230391760
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I): including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: October 13, 2021
    Publication date: December 7, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Xichen LIN, Andrew JENNINGS
  • HETEROCYCLIC GLP-1 AGONISTS
    Publication number: 20230331732
    Abstract: This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.
    Type: Application
    Filed: September 8, 2021
    Publication date: October 19, 2023
    Inventors: Qinghua MENG, Weiqiang XING, Haizhen ZHANG, Xichen LIN, Hui LEI, Andrew JENNINGS